Search Results

FILTER BY

1 - 12 of 29 matches

Sort by:
  • PresentationTCT 2022

    Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

    Presenter:  

    Rania Hammami

    September 19, 2022

  • PresentationESC 2022

    Colchicine and Rivaroxaban Plus Aspirin in Patients Hospitalized with COVID-19: A Factorial, Randomized, Open Trial

    Presenter:  

    Sanjit Jolly

    August 28, 2022

  • PresentationESC 2021

    Medically Ill Hospitalized Patients For COVID –19 Thrombosis Extended Prophylaxis With Rivaroxaban Therapy: THE MICHELLE TRIAL

    Presenter:  

    Eduardo Ramacciotti

    August 30, 2021

  • PresentationACC 2020

    VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

    Presenter:  

    William Hiatt

    March 29, 2020

  • PresentationJIM 2020

    Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

    Presenter:  

    Giuseppe Tarantini

    February 13, 2020

  • PresentationJIM 2019

    Consider Low Dose RIVAROXABAN + SAPT

    Presenter:  

    Roxana Mehran

    February 15, 2019

  • PresentationTCT 2018

    COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

    Presenter:  

    Deepak L. Bhatt, Michael Maeng, Tullio Palmerini

    September 23, 2018

  • PresentationESC 2018

    Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

    Presenter:  

    Alex C. Spyropoulos

    August 27, 2018

  • PresentationAHA 2017

    Cost Impact of Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial

    Presenter:  

    Andre Lamy

    November 15, 2017

  • PresentationTCT 2017

    The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice?

    Presenter:  

    C. Michael Gibson, Deepak L. Bhatt

    November 1, 2017

  • PresentationESC 2017

    Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

    Presenter:  

    John Eikelboom

    August 27, 2017

  • PresentationACC 2017

    A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

    Presenter:  

    Magnus Ohman

    March 27, 2017